Literature DB >> 7132366

Colorectal carcinoma: evaluation of histologic grade and factors influencing prognosis.

C K Chung, R J Zaino, J A Stryker.   

Abstract

We analyzed 246 patients with adenocarcinoma of colorectum treated with "curative" surgery alone. In reviewing these cases it is apparent that patients with poorly differentiated tumor (Grade 3) have an increased likelihood of deep invasion of tumor through the bowel wall and lymph node metastases compared to well (Grade 1) or moderately differentiated tumor (Grade 2). Poor differentiation of the tumor, deep penetration through the bowel wall and lymph node metastases appear to represent unfavorable prognostic indices in patients operated upon. Age, sex, size of primary tumor, and large bowel site of tumor origin were unrelated to the prognosis. Compared to Grade 1 and 2 tumors, patients with Grade 3 lesions had more local recurrences and/or distant metastases. These findings suggest that histologic grading is an important adjunct to the clinical evaluation and treatment planning of patients with colorectal carcinoma.

Entities:  

Mesh:

Year:  1982        PMID: 7132366     DOI: 10.1002/jso.2930210302

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  16 in total

Review 1.  Preoperative staging of gastrointestinal tumors by endosonography.

Authors:  K Ziegler; C Sanft; M Zeitz; E O Riecken
Journal:  Surg Endosc       Date:  1990       Impact factor: 4.584

2.  Periportal low attenuation associated with liver metastasis from colorectal cancer: evaluation using multi-detector-row CT with pathological correlation.

Authors:  Ryo Takaji; Shunro Matsumoto; Maki Kiyonaga; Yasunari Yamada; Hiromu Mori; Yukio Iwashita; Masayuki Ohta; Masafumi Inomata; Naoki Hijiya; Masatsugu Moriyama; Hajime Takaki; Kengo Fukuzawa; Hirotoshi Yonemasu
Journal:  Jpn J Radiol       Date:  2016-10-25       Impact factor: 2.374

3.  Moderately differentiated colorectal adenocarcinoma as a lymph node metastatic phenotype: comparison with well differentiated counterparts.

Authors:  Shozo Yokoyama; Katsunari Takifuji; Tsukasa Hotta; Kenji Matsuda; Toshiji Tominaga; Yoshimasa Oku; Toru Nasu; Koichi Tamura; Junji Ieda; Hiroki Yamaue
Journal:  BMC Surg       Date:  2010-03-08       Impact factor: 2.102

4.  The clinical significance of regional variations in histologic differentiation within carcinomas of the colorectum.

Authors:  H Kotanagi; T Fukuoka; Y Shibata; T Yoshioka; O Aizawa; K Koyama
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

5.  Endosonographic staging of rectal carcinoma.

Authors:  G Di Candio; F Mosca; A Campatelli; A Cei; M Ferrari; F Basolo
Journal:  Gastrointest Radiol       Date:  1987

6.  Colorectal carcinoma evaluated by incremental dynamic CT: comparison of CT density, histology, and tumor size.

Authors:  H Furukawa; T Hara; T Taniguchi
Journal:  Gastroenterol Jpn       Date:  1992-06

7.  Prognostic factors in 1,138 Iranian colorectal cancer patients.

Authors:  Bijan Moghimi-Dehkordi; Azadeh Safaee; Mohammad Reza Zali
Journal:  Int J Colorectal Dis       Date:  2008-03-11       Impact factor: 2.571

Review 8.  The clinical and biological significance of the transitional mucosa adjacent to colorectal cancer.

Authors:  Q A Wang; H Gao; Y H Wang; Y L Chen
Journal:  Jpn J Surg       Date:  1991-05

9.  VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese.

Authors:  Motohiro Yamamori; Mayuko Taniguchi; Shingo Maeda; Tsutomu Nakamura; Noboru Okamura; Akiko Kuwahara; Koichi Iwaki; Takao Tamura; Nobuo Aoyama; Svetlana Markova; Masato Kasuga; Katsuhiko Okumura; Toshiyuki Sakaeda
Journal:  Int J Med Sci       Date:  2008-04-08       Impact factor: 3.738

10.  Microsatellite instability in poorly differentiated adenocarcinomas of the colon and rectum: relationship to clinicopathological features.

Authors:  Yoshihiro Kazama; Toshiaki Watanabe; Takamitsu Kanazawa; Junichiro Tanaka; Toshiaki Tanaka; Hirokazu Nagawa
Journal:  J Clin Pathol       Date:  2007-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.